Skip to main content

Table 5 Cost-benefit

From: A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma

Outpatient-basis or home

Inpatient-basis

At home malignant tumor

Basic admission fee 472,900 yen

   Administration fee 25,000 yen

Local infusion technical fee (addition to minute infusion) 46,200 yen

Portable infuser pump

 

   using fee 15,000 yen

Diet 63,600 yen

Medication

Medication

   CDDP 20,000 yen

   CDDP 20,000 yen

   5-FU 15,000 yen

   5-FU 15,000 yen

Tumor marker 5,000 yen

Tumor marker 5,000 yen

Other laboratory test 8,400 yen

Other laboratory test 8,400 yen

Imaging diagnosis 15,000 yen

Imaging diagnosis 15,000 yen

(antiemeric drug 16,000 yen)

(antiemeric drug 16,000 yen)

Total 103,600 (119,600) yen

Total 646,300 (662,300) yen

  1. (One month treatment covered by Japanese National Health Insurance, A U.S. dollar is approximately equivalent to 104 Japanese yen)